Trial Profile
Single escalating IV doses of ligelizumab in patients with allergic asthma
Status:
Active, no longer recruiting
Phase of Trial:
Phase I
Latest Information Update: 30 Apr 2014
Price :
$35
*
At a glance
- Drugs Ligelizumab (Primary) ; Omalizumab
- Indications Allergic asthma
- Focus Adverse reactions; Pharmacodynamics; Pharmacokinetics
- 30 Apr 2014 New trial record